Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas
Status:
Active, not recruiting
Trial end date:
2022-11-09
Target enrollment:
Participant gender:
Summary
The general objective is to evaluate the consequences of surgical removal of SCSI on
hypertension and cardiovascular risk factors in order to determine on an evidence-based basis
if surgical excision of SCSI is preferable to an intensive medical regimen in patients with
hypertension.